Todd M. Enright Form 4 MusclePharm / MARK BLUNDELL ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

White Winston Select Asset Fund Series Fund MP-18, LLC

(Last) (First) (Middle)

265 FRANKLIN ST., SUITE 1702

(Street)

BOSTON MA 02110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MusclePharm Corp [ MSLP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/29/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/29/2022		S(1)		626,826	D	$0.00(2)	3,021,529	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

White Winston Select Asset Fund Series Fund MP-18, LLC

(Last) (First) (Middle)

265 FRANKLIN ST., SUITE 1702

(Street)

BOSTON MA 02110

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

White Winston Select Asset Funds, LLC

(Last) (First) (Middle)

265 FRANKLIN ST., SUITE 1702

(Street)

BOSTON MA 02110

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Enright Todd M.

(Last) (First) (Middle)

C/O WHITE WINSTON SELECT ASSET FUNDS, LL

265 FRANKLIN ST., SUITE 1702

(Street)

BOSTON MA 02110

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

BLUNDELL MARK

(Last) (First) (Middle)

C/O WHITE WINSTON SELECT ASSET FUNDS, LL

265 FRANKLIN ST., SUITE 1702

(Street)

BOSTON MA 02110

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Feagan Donald

(Last) (First) (Middle)

C/O WHITE WINSTON SELECT ASSET FUNDS, LL

265 FRANKLIN ST., SUITE 1702

(Street)

BOSTON MA 02110

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Mahoney Robert P

(Last) (First) (Middle)

C/O WHITE WINSTON SELECT ASSET FUNDS, LL

265 FRANKLIN ST., SUITE 1702

(Street)

BOSTON MA 02110

(City) (State) (Zip)

Explanation of Responses:

1. On March 29, 2022 (the "Transaction Date"), the Reporting Persons transferred 626,826 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), in an off-market transaction (the "Transaction").

2. For purposes of the Transaction, the value of the transferred shares of Common Stock was deemed to be $0.39 per share, the last reported sale price of the Issuer's Common Stock on the Transaction Date.

Remarks:

	White Winston Select Asset Fund Series Fund MP-18, By: White Winston Select Asset Funds, LLC, its Manager, By: /s/ Todd M. Enright, Manager	03/31/2022
	White Winston Select Asset Funds, LLC, By: /s/ Todd M. Enright, Manager	03/31/2022
	/s/ Todd M. Enright	03/31/2022
	/s/ Mark Blundell	03/31/2022
	/s/ Donald Feagan	03/31/2022
	/s/ Robert P. Mahoney	03/31/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.